-+ 0.00%
-+ 0.00%
-+ 0.00%

Vistagen Therapeutics Provides Update For U.S. Registration-Directed PALISADE-3 Phase 3 Trial Evaluating Fasedienol For Acute Treatment Of Social Anxiety Disorder

Benzinga·06/02/2025 12:34:24
Listen to the news

Company's PALISADE-4 Phase 3 trial now expected to read out in the first half of 2026